The prognostic significance of the lymph node ratio in axillary lymph node positive breast cancer

Journal of Breast Cancer

Volumn 14, Issue 3, 2011, Pages 204-212

  Kim, Ji Yoon ^a   Ryu, Mi Ryeong ^a   Choi, Byung Ock ^a   Park, Woo Chan ^a   Oh, Se Jeong ^a   Won, Jong Man ^a   Chung, Su Mi ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Breast neoplasms; Lymph nodes; Prognosis

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; PARAMETER; PREDICTION; RISK ASSESSMENT; TUMOR VOLUME;

EID: 80054731413     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2011.14.3.204     Document Type: Article

References (25)

1. Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK. Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 1999; 17: 2334-40.
2. Wilking N, Rutqvist LE, Carstensen J, Mattsson A, Skoog L. Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of respected nodes. Stockholm Breast Cancer Study Group. Acta Oncol 1992;31:29-35.
3. Schaapveld M, Otter R, de Vries EG, Fidler V, Grond JA, van der Graaf WT, et al. Variability in axillary lymph node dissection for breast cancer. J Surg Oncol 2004;87:4-12.
4. Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G. Te lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol 2004;70:225-30.
5. Woodward WA, Vinh-Hung V, Ueno NT, Cheng YC, Royce M, Tai P, et al. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 2006;24:2910-6.
6. Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, Vlastos G, et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 2009;27:1062-8.
7. van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol 2002; 28:481-9.
8. Kuru B. Prognostic significance of total number of nodes removed negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma. Eur J Surg Oncol 2006;32:1082-8.
9. Lale Atahan I, Yildiz F, Ozyigit G, Sari S, Gurkaynak M, Selek U, et al. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Acta Oncol 2008;47:232-8.
10. Kim JY, Lim HI, Lee SK, Choi JH, Kim WW, Choe JH, et al. The impact of the ratio of positive nodes to removed nodes on recurrence and overall survival in node positive breast cancer patients. J Breast Cancer 2008; 11:194-200.
11. Grills IS, Kestin LL, Goldstein N, Mitchell C, Martinez A, Ingold J, et al. Risk factors for regional nodal failure afer breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int J Radiat Oncol Biol Phys 2003; 56:658-70.
12. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC Cancer Staging Manual 6th ed New York: Springer; 2002. p. 223-36.
13. Veronesi U, Rilke F, Luini A, Sacchini V, Galimberti V, Campa T, et al. Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. Cancer 1987;59:682-7.
14. Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992;69:2496-501.
15. Kuru B, Bozgul M. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma. Int J Radiat Oncol Biol Phys 2006; 66:1328-34.
16. Hack TF, Cohen L, Katz J, Robson LS, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999; 17:143-9.
17. Forrest AP, Everington D, McDonald CC, Steele RJ, Chetty U, Stewart HJ. The Edinburgh randomized trial of axillary sampling or clearance after mastectomy. Br J Surg 1995;82:1504-8.
18. Lambah A, Dixon JM, Prescott RJ, Jack W, Forrest AP, Rodger A, et al. Randomised study of axillary clearance versus four node sampling. Eur J Cancer 2001;37(Suppl5):2.
19. Chetty U, Jack W, Prescott RJ, Tyler C, Rodger A. Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit Br J Surg 2000;87:163-9.
20. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radio-localization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-9.
21. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg 2008;206:239-46.
22. De Ridder M, Vinh-Hung V, Van Nieuwenhove Y, Hoorens A, Sermeus A, Storme G. Prognostic value of the lymph node ratio in node positive colon cancer. Gut2006;55:1681.
23. Chan JK, Kapp DS, Cheung MK, Osann K, Shin JY Cohn D, et al. The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients. Br J Cancer 2007;97: 605-11.
24. Farshid G, Pradhan M, Kollias J, Gill PG. A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node. Breast 2004;13:494-501.
25. Barranger E, Coutant C, Flahault A, Delpech Y Darai E, Uzan S. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 2005;91:113-9.